{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:06:38Z","timestamp":1773273998186,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science of the Republic of Serbia","award":["175041"],"award-info":[{"award-number":["175041"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Anemia is common among patients with antiphospholipid syndrome (APS). It can persist alone (primary APS\u2014pAPS) or with another associated disease (secondary APS\u2014sAPS), predominantly systemic lupus erythematosus (SLE). There are no systematic reviews addressing the type of anemia (iron deficiency without anemia\u2014IDWA, iron deficiency\u2014IDA, and anemia of chronic disease\u2014ACD) in these patients. Objectives: This study aimed to assess the type of anemia and to compare the usefulness of common diagnostic anemia parameters and their mutual relations. Methods: A cross-sectional study involving 163 patients was conducted at the University Clinical Center Bezanijska kosa from June 2022 to June 2024, including 79 patients with pAPS, 47 with sAPS and 37 patients diagnosed with SLE. We compared the usefulness of iron metabolism markers (serum iron\u2014Fe; total iron-binding capacity\u2014TIBC; ferritin; hepcidin) in the presence of inflammatory markers such as high-sensitivity (hsCRP) and IL6 in determining the type of anemia. Results: The most common types were IDA (61.9%) and IDWA (64.3%) in pAPS patients. In contrast, ACD was equally distributed across the three groups, with prevalences of 32%, 32%, and 36% (pAPS, sAPS, and SLE, respectively). A higher frequency of thrombosis was significantly associated with a high ferritin level \u2265100 (p = 0.017) and high IL6 levels (p = 0.033) as well as fetal losses (p = 0.034 and p = 0.019, respectively). The logistic regression model identified ferritin as the only significant predictor of IDA (p = 0.023). For IDWA, both ferritin (p = 0.017) and hepcidin (p = 0.038) were significant predictors of this type of iron depletion. IL-6 levels were significantly correlated with ferritin and hsCRP levels (p = 0.004 and p = 0.007, respectively). In contrast, hepcidin did not show a statistically significant correlation with inflammatory markers. A total of 40% of patients with IDA had hepcidin levels below 10, and 48% of those with ACD had hepcidin levels above 10 (p = 0.036). Conclusions: It was found that iron deficiency anemia was the most common form in pAPS, while anemia of chronic disease was equally present across all patient groups. Ferritin emerged as an independent marker for identifying iron deficiency anemia in APS patients. Although hepcidin reflects a low-inflammatory state in APS, it proved to be a more valuable tool than ferritin in distinguishing the type of anemia, especially when ferritin levels were inconclusive. Clinical manifestations in APS patients correlated with inflammatory markers. Liver function or any drug used alone or in combination had no impact on anemia type.<\/jats:p>","DOI":"10.3390\/diseases14030101","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:00:37Z","timestamp":1773219637000},"page":"101","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Prevalence of Anemia and Diagnostic Usefulness of Ferritin and Hepcidin in Antiphospholipid Syndrome and Systemic Lupus Erythematosus Patients"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1496-9034","authenticated-orcid":false,"given":"Natasa","family":"Stanisavljevic","sequence":"first","affiliation":[{"name":"University Clinical Center \u201cBezanijska Kosa\u201d, 11080 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-2513","authenticated-orcid":false,"given":"Ljudmila","family":"Stojanovich","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Special Hospital \u201cZutic\u201d, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6094-7306","authenticated-orcid":false,"given":"Aleksandra","family":"Djokovic","sequence":"additional","affiliation":[{"name":"University Clinical Center \u201cBezanijska Kosa\u201d, 11080 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Dopsaj","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2641-9817","authenticated-orcid":false,"given":"Neda","family":"Milinkovic","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusica","family":"Mrdakovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-0716","authenticated-orcid":false,"given":"Olivera","family":"Markovic","sequence":"additional","affiliation":[{"name":"University Clinical Center \u201cBezanijska Kosa\u201d, 11080 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-0263","authenticated-orcid":false,"given":"Marija","family":"Zdravkovic","sequence":"additional","affiliation":[{"name":"University Clinical Center \u201cBezanijska Kosa\u201d, 11080 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragomir","family":"Marisavljevic","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/BOR.0000000000000926","article-title":"An update on inflammation in antiphospholipid syndrome (APS)","volume":"35","author":"Ambati","year":"2023","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101015","DOI":"10.1016\/j.blre.2022.101015","article-title":"Hematological manifestations of antiphospholipid syndrome: Going beyond thrombosis","volume":"58","author":"Hasbani","year":"2023","journal-title":"Blood Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5606\/tjr.2013.2717","article-title":"The prevalence of iron deficiency anemia in primary antiphospholipid syndrome","volume":"28","author":"Klack","year":"2013","journal-title":"Arch. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxh229","article-title":"Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with antiphospholipid syndrome","volume":"17","author":"Simoncini","year":"2005","journal-title":"Int. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/ard.2005.041673","article-title":"Anaemia in systemic lupus erythematosus: From pathophysiology to clinical assessment","volume":"65","author":"Giannouli","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"001S","DOI":"10.1093\/jn\/nxx036","article-title":"Biomarkers of Nutrition for Development (BOND)\u2014Iron Review","volume":"148","author":"Lynch","year":"2018","journal-title":"J. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1177\/0961203313504633","article-title":"Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)","volume":"22","author":"Katz","year":"2013","journal-title":"Lupus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_10","unstructured":"World Health Organization (2026, February 02). Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity, Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-NMH-NHD-MNM-11.1."},{"key":"ref_11","first-page":"107","article-title":"Iron deficiency without anaemia: A diagnosis that matters","volume":"2","author":"Sallam","year":"2021","journal-title":"Clin. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ccr3.1529","article-title":"Iron deficiency without anemia\u2014A clinical challenge","volume":"6","author":"Soppi","year":"2018","journal-title":"Clin. Case Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ajh.24820","article-title":"Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management","volume":"92","author":"Cappellini","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_14","first-page":"11S","article-title":"The nutritional assessment of iron status","volume":"49","author":"Cook","year":"1999","journal-title":"Arch. Latinoam. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","article-title":"Serum hepcidin: Reference ranges and biochemical correlates in the general Population","volume":"117","author":"Galesloot","year":"2011","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jalm\/jfaa038","article-title":"Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors","volume":"5","author":"Gutschow","year":"2020","journal-title":"J. Appl. Lab. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1002\/jmv.26654","article-title":"Defining IL-6 levels in healthy individuals: A meta-analysis","volume":"93","author":"Said","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection","volume":"7","author":"Pengo","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.autrev.2009.04.001","article-title":"Antiphospholipid antibodies and malignancies","volume":"9","author":"Tincani","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The Hyperferritinemic Syndrome: Macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Rosario","year":"2013","journal-title":"BMC Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1182\/blood-2002-08-2459","article-title":"Cytokine-mediated regulation of iron transport in human monocytic cells","volume":"101","author":"Ludwiczek","year":"2003","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/ejh.12402","article-title":"Hepcidin in tumor related iron deficiency anemia and tumor-related anemia of chronic disease: Pathogenic mechanisms and diagnosis","volume":"94","author":"Shu","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1002\/art.30623","article-title":"Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia","volume":"63","author":"Laarakkers","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1097\/MIB.0b013e31829a6e43","article-title":"Serum hepcidin in inflammatory bowel diseases: Biological and clinical significance","volume":"19","author":"Bergamaschi","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s00134-010-1794-8","article-title":"Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia","volume":"36","author":"Lasocki","year":"2010","journal-title":"Intensive Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.clinbiochem.2008.08.079","article-title":"High-sensitivity C-reactive protein: Discriminator between patients with primary and secondary antiphospholipid syndrome","volume":"41","author":"Becarevic","year":"2008","journal-title":"Clin. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","article-title":"Coagulation factors, inflammation markers, and venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)","volume":"113","author":"Tsai","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/acr.21841","article-title":"High sensitivity C-reactive protein, disease activity and cardiovascular risk factors in systemic lupus erythematosus","volume":"65","author":"Mok","year":"2013","journal-title":"Arthritis Care Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/ard.2004.022681","article-title":"Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anemia","volume":"64","author":"Ripley","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1093\/rheumatology\/keaf281","article-title":"Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors","volume":"64","author":"Hempel","year":"2025","journal-title":"Rheumatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1182\/blood-2023-190934","article-title":"Association between Iron Deficiency Anemia and Thrombosis, a Population Based Study","volume":"142","author":"Laber","year":"2023","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3324\/haematol.2020.270496","article-title":"Recognition of thrombotic risk of thrombocytosis in iron deficiency","volume":"106","author":"Samkari","year":"2021","journal-title":"Haematologica"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"103447","DOI":"10.1016\/j.autrev.2023.103447","article-title":"Risk of venous thromboembolism in autoimmune diseases: A comprehensive review","volume":"22","author":"Menichelli","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s11239-020-02155-y","article-title":"Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome","volume":"50","author":"Arantes","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_35","first-page":"1875","article-title":"Relevance of inflammatory and complement activation biomarkers profiling in antiphospholipid syndrome patients outside acute thrombosis","volume":"41","author":"Yelnik","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1076029610369797","article-title":"Antiphospholipid Antibodies and Antiphospholipid Syndrome: Role in Portal Vein Thrombosis in Patients with and Without Liver Cirrhosis","volume":"17","author":"Amitrano","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cca.2009.03.001","article-title":"Beta2-glycoprotein-I plasma levels in liver cirrhosis","volume":"403","author":"Gries","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.30383","article-title":"Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen \u03b22-glycoprotein I","volume":"63","author":"Ioannou","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"103112","DOI":"10.1016\/j.jaut.2023.103112","article-title":"mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency","volume":"140","author":"Winans","year":"2023","journal-title":"J. Autoimmun."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/3\/101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:38:11Z","timestamp":1773221891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/3\/101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["diseases14030101"],"URL":"https:\/\/doi.org\/10.3390\/diseases14030101","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}